A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
|Podcasts|March 25, 2021
S3E4: LARC in the time of COVID-19 and telehealth: Part 1
Author(s)Lindsey Carr, Editor
In this episode, Dr. Rachel Phelps of the Rochester LARC Initiative sits down with Dr. Amber Trueheart of the University of Chicago Department of Obstetrics and Gynecology.
Advertisement
Stay tuned for Part 2.
Advertisement
Related to this article
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Anita Nelson, MD, discusses the FDA's approval extending etonogestrel implant use to 5 years and the new REMS certification clinicians must complete by February 23, 2027.
A review finds post-miscarriage ultrasound heterogeneity is common and that symptoms, not endometrial thickness, should guide management after EPL.
Marla Shapiro, MDCM, explains how OPTION-VMS actigraphy data corroborated patient-reported sleep improvements with fezolinetant (Veozah) as early as week 4.
Soma Mandal, MD, is launching “Mind, Body, & the Pause: the Perimenopause and Beyond Series” on Contemporary OB/GYN, featuring specialists from across Hackensack Meridian Health.
Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Low birth volume and unprofitability associated with obstetric services losses
2
Ultrasound findings after medication management of early pregnancy loss
3
Soma Mandal, MD, to launch 'Mind, Body, & the Pause' perimenopause podcast on Contemporary OB/GYN
4
Actigraphy supports fezolinetant sleep improvements by week 4
5